-
1 Comment
Nanjing Hicin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 6.2% below its 200 day moving average.
From a valuation standpoint, the stock is 69.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Nanjing Hicin Pharmaceutical Co., Ltd's total revenue sank by 24.8% to $172M since the same quarter in the previous year.
Its net income has dropped by 51.9% to $12M since the same quarter in the previous year.
Finally, its free cash flow grew by 180.1% to $22M since the same quarter in the previous year.
Based on the above factors, Nanjing Hicin Pharmaceutical Co., Ltd gets an overall score of 2/5.
| ISIN | CNE100002F44 |
|---|---|
| CurrencyCode | CNY |
| Exchange | SHE |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector | Healthcare |
| PE Ratio | 10.48 |
|---|---|
| Beta | 0.33 |
| Dividend Yield | 1.0% |
| Target Price | None |
| Market Cap | 3B |
Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300584.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
